James Torosian is a Philadelphia, Pennsylvania based Periodontics who is specialized in Periodontology. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1500 Locust St, Suite 1408, Philadelphia. Patients can reach him at 215-732-4450.
James Torosian is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
James Torosian speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
James Torosian
Specialization:
Periodontics
Gender:
Male
Credentials:
D.M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
1500 Locust St, Suite 1408, Philadelphia, Pennsylvania, 19102-4329
Phone:
215-732-4450
Fax:
215-735-9886
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3870814015
Enrollment ID:
I20150601000447
NPI Number:
1144361767
NPI Enumeration Date:
08 Feb, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1500 Locust St, Suite 1408 Philadelphia, Pennsylvania
Zip:
19102-4329
Phone Number:
215-732-4450
Fax Number:
215-735-9886
Patients can reach James Torosian at 1500 Locust St, Suite 1408, Philadelphia, Pennsylvania or can call to book an appointment on 215-732-4450. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.